Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-28 @ 9:59 PM
Study NCT ID:
NCT02728934
Status:
COMPLETED
Last Update Posted:
2020-04-15
First Post:
2016-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis
Sponsor:
Janssen Scientific Affairs, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-31
First Submit QC Date:
None
Study First Post Date:
2016-04-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-14
Last Update Post Date:
2020-04-15
Last Update Post Date Type:
ACTUAL